The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.

Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.

An extract from plant material of the New Zealand native fern tree mamaku (Cyathea medullaris) which has been processed under gentle conditions to provide an effective treatment for eczema.

An extract from plant material of the New Zealand native fern tree mamaku (Cyathea medullaris) which has been processed under gentle conditions to provide an effective treatment for eczema.

A sustained culture of isolated avian gonocytes is provided, as well as a method of making and using the same. A chimeric avian containing an isolated gonocyte and a transgenic avian produced using the chimeric avian are also provided. The cell and method may be employed to make, among other things, transgenic avian that produce a heterologous protein, e.g., a therapeutic protein.

Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.

A composition includes the following active components: component (1): at least one selected from the group consisting of Ligustrum fruit, yerbadetajo herb, Lilium bulb, Polygonatum Rhizome, Lycium fruit, Sesamum indicum, and black soybean; component (2): at least one selected from the group consisting of Suberect spatholobus stem, Longan aril, wild turmeric, zedoary root, Luffa vegetable sponge, Sparganium rhizome, safflower, Artemisia anomala, common fenugreek seed, Dipsacus japonicus root, Drynaria herb, sea horse, Cynomorium herb, and Astragalus Seed; component (3): at least one selected from the group consisting of tea leaf, plantago seed, plantago herb, coix seed, small red-bean, corn silk, Lophatherum herb, Benincasa seed, mallow seed, knotgrass, and Lygodium spore; and component (4): at least one selected from the group consisting of Dioscorea japonica Thunberg, Eleutherococcus senticosus Rhizome, honey, oriental bush cherry, ginger root, ripe tangerine peel, unripe tangerine peel, immature orange, malt starch syrup, jujube fruit, and non-glutinous rice.